Cancer diagnostics company Pacific Edge reported a net loss of $17.9 million for the year ending March 31 2019. With just $12.9m of cash or cash equivalents, at the reported rate of revenue and expenditure, the company will exhaust existing funds by the end of this year.
The company’s total
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
